Disulfide-rich macrocyclic peptides as templates in drug design
- 1 April 2014
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 77, 248-257
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma TreatmentMolecular Therapy Nucleic Acids, 2013
- Chemical Synthesis of Naturally‐Occurring Cyclic Mini‐Proteins from Plants and AnimalsIsrael Journal of Chemistry, 2011
- Protease-Resistant Peptide Ligands from a Knottin Scaffold LibraryACS Chemical Biology, 2011
- Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted TherapyJournal of Medicinal Chemistry, 2011
- Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic EffectsJournal of Biological Chemistry, 2010
- Hepcidin Revisited, Disulfide Connectivity, Dynamics, and StructureJournal of Biological Chemistry, 2009
- Retrocyclins Kill Bacilli and Germinating Spores of Bacillus anthracis and Inactivate Anthrax Lethal ToxinJournal of Biological Chemistry, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporterNature Neuroscience, 2001
- Solution structures by 1 H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant 1 1Edited by M. F. SummersJournal of Molecular Biology, 2001